A phase I study of combined UFT plus leucovorin and radiotherapy for pancreatic cancer

International Journal of Radiation Oncology Biology Physics

Volumn 47, Issue 4, 2000, Pages 939-944

  Childs, Hoyt A ^a   Spencer, Sharon A ^a   Raben, David ^a   Bonner, James A ^a   Newsome, Jennifer ^a   Robert, Francisco ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Leucovorin; Pancreatic; Radiation; UFT

Indexed keywords

FOLINIC ACID; UFT;

ADULT; AGED; ANOREXIA; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; DIARRHEA; DOSE RESPONSE; DRUG EFFICACY; FATIGUE; HUMAN; METASTASIS; NAUSEA; NEUTROPENIA; PANCREAS CANCER; PATIENT COMPLIANCE; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

ADENOCARCINOMA; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; COMBINED MODALITY THERAPY; DIARRHEA; FEMALE; HUMANS; LEUCOVORIN; MALE; MIDDLE AGED; NEUTROPENIA; PANCREATIC NEOPLASMS; TEGAFUR; URACIL;

EID: 0034237247     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(00)00496-X     Document Type: Article

References (25)

1. Cancer Facts & Figures - 1998. American Cancer Society; 1998. p. 4.
2. Evans D.B., Abbruzzese J.L., Rich T.A. Cancer of the pancreas. DeVita V.T. Jr, Hellman S., Rosenberg S.A. Cancer, principles and practice of oncology. 5th ed. 1997;1054-1087 Lippincott-Raven Press, New York.
3. Kalser M.H., Ellenberg S.S. Pancreatic cancer Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 120:(8):1985;899-903.
4. Moertel C.G., Frytak S., Hahn R.G., et al. Gastrointestinal Tumor Study Group Therapy of locally unresectable pancreatic carcinoma: A randomized comparison of high dose (6000 rads) radiation alone, moderate dose radiation (4000 rads + 5 fluorouracil), and high dose radiation and 5 fluorouracil. Cancer. 48:(8):1981;1705-1710.
5. Klaassen D.J., MacIntyre J.M., Catton G.E., et al. Treatment of locally unresectable cancer of the stomach and pancreas A randomized comparison of 5-flourouracil alone with radiation plus concurrent and maintenance 5-flourouracil - An Eastern Cooperative Oncology Group Study. J Clin Oncol. 3:1985;373-378.
6. Moertel C.T., Childs D.S. Jr, Reitmeir R.J., et al. Combined 5-flourouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer. Lancet. 2:1969;865-867.
7. Comparative therapeutic trial of radiation with or without chemotherapy in pancreatic carcinoma. Int J Radiat Oncol Biol Phys. 5:(9):1979;1643-1647.
8. Radiation therapy combined with Adriamycin or 5-flououracil for the treatment of locally unresectable pancreatic carcinoma. Cancer. 56:(11):1985;2653-2658.
9. Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Cancer. 59:(12):1987;2006-2010.
10. Treatment of locally unresectable carcinoma of the pancreas Comparison of combined modality therapy (chemotherapy plus radiotherapy) to chemotherapy alone. J Natl Cancer Inst. 80:(20):1988;751-755.
11. Dobelbower R.R. The radiotherapy of pancreatic cancer. Semin Oncol. 6:(3):1979;378-379.
12. Mohiuddin M., Cantor R.J., Biermann W., et al. Combined modality treatment of localized unresectable adenocarcinoma of the pancreas. Int J Radiat Oncol Biol Phys. 14:(1):1987;79-84.
13. Byfield J.E., Calabro-Jones P., Klisak I., et al. Pharmacologic requirements for obtaining sensitization of human tumor cells in vitro to combined 5-flourouracil or ftotafur and x-rays. Int J Radiat Oncol Biol Phys. 8:1982;1923-1933.
14. O'Connell M., Martenson J.A., Weiand H.S., et al. Improving adjuvant therapy for rectal cancer by combining protracted infusion fluorouracil with radiation therapy after curative surgery. N Engl J Med. 331:(8):1994;502-507.
15. Whittington R., Neuberg D., Tester W.J., et al. Protracted intravenous fluorouracil infusion with radiation therapy in the management of localized pancreaticobiliary carcinoma A Phase I Eastern Cooperative Group Trial. J Clin Oncol. 13:1995;227-232.
16. Evans BE, Abbruzzese JL, Rich TA. Cancer of the pancreas. In: DeVita VT, Hellman S, Rosenberg SA, editors. Cancer, principles and practice of oncology. 5th ed. Vol. 1. Philadelphia: Lippincott-Raven Publishers; 1997 p. 1061.
17. Miller A., Hoogstraten B., Strquet M., et al. Reporting results of cancer treatment. Cancer. 47:1981;207-214.
18. Wittes R.E. Manual of oncologic therapeutics. 1989;627 JB Lippincott, Philadelphia.
19. Le C.T. Applied survival analysis. 1997;J2-J7 John Wiley and Sons, New York.
20. Ota K., Taguchi T., Kimura K. Report on nationwide pooled data and cohort investigation in UFT phase II study. Cancer Chemother Pharmacol. 22:1988;333-338.
21. Aranda E., Antón-Torres A., Sastre J., et al. UFT plus leucovorin (LV) in advanced colorectal cancer (CCR). A phase II trial (Abstr. 940). Proc Am Soc of Clin Oncol. 18:1999;141a.
22. Pazdur R., Lassere Y., Rhodes V., et al. Phase II trial of uracil and tegafur plus oral leucovorin An effective oral regimen in the treatment of metastatic colorectal carcinoma. J Clin Oncol. 12:(11):1994;2296-2300.
23. Pazdur R. Phase II study of UFT plus leucovorin in colorectal cancer. Oncology. 54:(Suppl. 1):1997;19-23.
24. Saltz L.B., Leichman C.G., Young C.W., et al. A fixed-ratio combination of uracil and ftotafur (UFT) with low dose leucovorin An active oral regimen for advanced colorectal cancer. Cancer. 75:1995;782-785.
25. Childs H.A., Spencer S.A., Raben D., et al. Phase I study of combined UFT plus leucovorin and radiation therapy for pancreatic cancer. (Abstr. 956) Proc Am Soc Clin Oncol. 18:1999;249a.